Venture&Growth
Location
Dublin, Ireland
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Irish MedTech company focused on remote monitoring of heart failure patients.
FIRE1 is a connected medical device solutions company dedicated to improving outcomes for people suffering from chronic diseases. Its first product is a novel remote monitoring solution for heart failure patients. FIRE1 is led by an experienced medical devices team who are working closely with researchers, clinicians, patients and payors to help reduce the burden of heart failure.
More Fire1 news
Gilde Healthcare company FIRE1 raises $25 million to revolutionize heart failure home monitoring
Gilde Healthcare leads EUR 40 Million financing in Irish healthtech company FIRE1
Venture&Growth
Okami Medical
Okami Medical, based in Aliso Viejo, California and founded in 2017 by the Inari team through the Inceptus Medical incubator, is a commercial-stage company focused on innovative solutions for peripheral vascular embolization across a wide range of conditions. The company’s
Venture&Growth
Affimed
Affimed (Nasdaq: AFMD) is a German therapeutics company committed to utilizing the untapped potential of the innate immune system to restore patients’ natural ability to fight cancer. Affimed is developing a product pipeline consisting of three clinical-stage drug candidates, providing
Venture&Growth
Purespring Therapeutics
Founded in 2020, Purespring is a pioneering London (UK)-based gene therapy company focused on transforming treatments for patients suffering from chronic kidney diseases. It is the first company to successfully treat kidney disease by targeting the podocyte, a specialised cell
